A critical review of the treatment of migrainous neuralgia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002574:Cervical Vertebrae; D002648:Child; D004357:Drug Synergism; D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008784:Methysergide / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D009437:Neuralgia / Q000188:drug therapy* / Q000601:surgery; D013562:Sympathectomy; D014839:Vomiting / Q000139:chemically induced
D004878:Ergotamine; D008784:Methysergide